Ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome: A pharmacodynamic analysis.
Department of Cardiology, The Chinese PLA General Hospital (301 Hospital), Beijing 100853, China. Electronic address: cyundai@vip.163.com.
Yundai
Y
Chen
Department of Cardiology, The Chinese PLA General Hospital (301 Hospital), Beijing 100853, China.
Wei
W
Dong
Department of Cardiology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Zheng
Z
Wan
Department of Cardiology, The People's Hospital of Liaoning Province, Shenyang 110016, China.
Zhanquan
Z
Li
Department of Cardiology, Tianjin Chest Hospital, Tianjin 300051, China.
Hongliang
H
Cong
Department of Cardiology, Peking University First Hospital, Beijing 100034, China.
Tao
T
Hong
Department of Cardiology, The Chinese PLA General Hospital (301 Hospital), Beijing 100853, China.
Tong
T
Yin
D054058:Acute Coronary Syndrome / Q000188:drug therapy / Q000378:metabolism*; D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D000077144:Clopidogrel; D005500:Follow-Up Studies; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000077486:Ticagrelor; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000077144:Clopidogrel; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine; D001241:Aspirin
Acute coronary syndromes; Antiplatelet; Clopidogrel; Ticagrelor